Bioserenity
Private Company
Funding information not available
Overview
Bioserenity is a private, commercial-stage company offering a vertically integrated platform for neurology and sleep diagnostics, combining FDA/CE-certified hardware, AI software, and telemedicine services. Founded in 2014, it has established a network of 200+ hospital partners and a community of 9,000 physicians, processing 60,000 remote interpretations in 2023. The company is leveraging its large real-world electrophysiology database to develop AI foundation models, positioning itself at the intersection of medical devices, diagnostics, and digital health.
Technology Platform
Integrated platform combining connected medical devices (EEG caps, portable Neuronaute+ system), a cloud-based AI software suite for data analysis, and a telemedicine network for remote specialist interpretation.
Opportunities
Risk Factors
Competitive Landscape
Bioserenity competes with traditional medical device companies selling EEG systems, other digital health startups offering remote monitoring solutions, and tech companies developing AI for healthcare. Its integrated hardware-software-telemedicine model and focus on neurology/sleep provide differentiation, but it must continuously innovate to stay ahead.